BACKGROUND: Lung and Bronchus cancer is the most fatal type of cancer in the United States. According to the American Cancer Society, there were more than 127,000 deaths from lung cancer in 2023. Lung cancer care cost 23.8 billion dollars in 2020. In...
Cancer diagnosis at an early stage is crucial for improving overall health outcomes. However, existing cancer diagnostic techniques are mostly invasive and tend to identify the disease only in its advanced stages. MicroRNAs (miRNAs), which are small ...
In recent years, there has been a significant increase in research activity on electroencephalography (EEG)-based motor imagery brain-computer interfaces (MI-BCI) in the field of deep learning. However, despite achieving high accuracy, the size of mo...
Noninvasive diagnostic approaches are essential for early detection, patient compliance, and reduction of healthcare burden, yet they often face limitations in sensitivity, specificity, and timely interpretation. Artificial intelligence (AI) and mach...
Phytomedicine : international journal of phytotherapy and phytopharmacology
Oct 30, 2025
BACKGROUND: Target identification is fundamental to drug discovery, facilitating mechanistic elucidation and therapeutic target identification. Traditional herbal medicines exert therapeutic effects through multi-component, multi-target synergistic m...
Older individuals frequently experience hearing difficulties, often due to sensorineural hearing loss (HL) primarily originating in the inner ear. However, it is not uncommon for older adults with HL to also exhibit impairments in speech intelligibil...
Overrepresentation analysis is used to identify biological enrichment in a list of genes. Here, we introduce GeneTEA, a model that ingests free-text gene descriptions and incorporates natural language processing methods to learn a sparse gene-by-term...
Modern Artificial Intelligence (AI) has demonstrated its effectiveness by achieving human-level performance in various complex tasks, including the biomedical field. Cancer research, adapting to a fast-changing world, is leveraging AI as a promising ...
BACKGROUND: Lung adenocarcinoma (LUAD), a subtype of non-small cell lung cancer (NSCLC), has high incidence and poor prognosis. Although anti-programmed cell death protein 1 (PD1) therapy and epidermal growth factor receptor (EGFR) inhibitors benefit...
Artificial intelligence (AI) is rapidly revolutionizing the landscape of oncological research and the advancement of personalized clinical interventions. Progress in three interconnected areas, including the development of methods and algorithms for ...
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.